Exploiting the CRISPR‐Cas9 gene‐editing system for human cancers and immunotherapy.

Autor: Afolabi, Lukman O1,2,3 (AUTHOR), Afolabi, Mariam O4,5 (AUTHOR), Sani, Musbahu M3 (AUTHOR), Okunowo, Wahab O6 (AUTHOR), Yan, Dehong1,2 (AUTHOR), Chen, Liang1,2 (AUTHOR), Zhang, Yaou4,5,7 (AUTHOR) zhangyo@sz.tsinghua.edu.cn, Wan, Xiaochun1,2 (AUTHOR) xc.wan@siat.ac.cn
Zdroj: Clinical & Translational Immunology. 2021, Vol. 10 Issue 6, p1-23. 23p.
Databáze: Academic Search Ultimate